A prospective analysis of the management practices for patients with Stage-III-N2Non-Small-Cell lung cancer (OBSERVE IIIA-B GFPC 04-2020Study).
Mathilde JacobPierre FournelClaire TissotJacques CadranelOlivier BylickiIsabelle MonnetGrégoire JusteauCharles RicordelPascal ThomasLionel FalcheroChrystel LocherMarie WislezAlain VergnenegreSamir AbdicheFloran GuisierAcya BizieuxRegine LamyGeraldine FrançoisGonzagues De ChabotThomas PierretMarie SabatiniMarion AbeilleraSabine VieillotStephanie MartinezHugues MorelHélène DoubreAnne MadroszykMargaux GeierJean LucLaboureyChristos ChouaïdLaurent GreillierPublished in: Lung cancer (Amsterdam, Netherlands) (2024)
The results of this study highlight substantial disparities amongFrench TBMs regarding therapeutic management of stage-III-N2 NSCLC. The decisions were not associated with local conditions.